Chief Executive Officer Traversa Sergio bought $113,300 worth of shares (27,500 units at $4.12), increasing direct ownership by 2% to 1,300,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

RLMD· Relmada Therapeutics Inc.

Health Care

Original source

Chief Executive Officer Traversa Sergio bought $113,300 worth of shares (27,500 units at $4.12), increasing direct ownership by 2% to 1,300,000 units (SEC Form 4) | Quantisnow